SUBLOCADE

NDC 12496-0300 · Indivior Inc.

Generic namebuprenorphine

Dosage formSOLUTION

RouteSUBCUTANEOUS

Active ingredient(s)BUPRENORPHINE

Strength300 mg/1

Pharmacologic classPartial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]

DEA scheduleCIII

Marketing categoryNDA

Packages

12496-0300-1 — 1 POUCH in 1 CARTON (12496-0300-1) / 1 SYRINGE in 1 POUCH (12496-0300-2) / 1 SOLUTION in 1 SYRINGE (12496-0300-5)

Q9992 — Injection, buprenorphine extended-release (sublocade), greater than 100 mg Medicare Part B payment limit (ASP + 6%): $2068.16

FDA lists these products with the same active ingredient.

0093-3239 — Buprenorphine, 0093-3656 — Buprenorphine, 0093-3657 — Buprenorphine, 0093-3658 — Buprenorphine, 0093-3659 — Buprenorphine, 12496-0100 — buprenorphine, 3215-1521 — Buprenorphine, 3215-1522 — Buprenorphine, 3215-1523 — Buprenorphine, 3215-1524 — Buprenorphine, 3215-1525 — Buprenorphine, 42858-353 — Buprenorphine, 42858-493 — Buprenorphine, 42858-586 — Buprenorphine, 42858-750 — Buprenorphine, 42858-839 — Buprenorphine, 47781-406 — buprenorphine, 47781-407 — buprenorphine, 47781-408 — buprenorphine, 47781-419 — buprenorphine, +27 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.